Prell RA - Search Results

1

The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement.

Weinberg AD, Evans DE, Thalhofer C, Shi T, Prell RA. Weinberg AD, et al. Among authors: prell ra. J Leukoc Biol. 2004 Jun;75(6):962-72. doi: 10.1189/jlb.1103586. Epub 2004 Mar 2. J Leukoc Biol. 2004. PMID: 14996827 Review.

2

OX40-mediated memory T cell generation is TNF receptor-associated factor 2 dependent.

Prell RA, Evans DE, Thalhofer C, Shi T, Funatake C, Weinberg AD. Prell RA, et al. J Immunol. 2003 Dec 1;171(11):5997-6005. doi: 10.4049/jimmunol.171.11.5997. J Immunol. 2003. PMID: 14634111

3

Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4.

Evans DE, Prell RA, Thalhofer CJ, Hurwitz AA, Weinberg AD. Evans DE, et al. Among authors: prell ra. J Immunol. 2001 Dec 15;167(12):6804-11. doi: 10.4049/jimmunol.167.12.6804. J Immunol. 2001. PMID: 11739496

4

Engagement of the OX-40 receptor in vivo enhances antitumor immunity.

Weinberg AD, Rivera MM, Prell R, Morris A, Ramstad T, Vetto JT, Urba WJ, Alvord G, Bunce C, Shields J. Weinberg AD, et al. J Immunol. 2000 Feb 15;164(4):2160-9. doi: 10.4049/jimmunol.164.4.2160. J Immunol. 2000. PMID: 10657670

5

Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion.

Maxwell JR, Weinberg A, Prell RA, Vella AT. Maxwell JR, et al. Among authors: prell ra. J Immunol. 2000 Jan 1;164(1):107-12. doi: 10.4049/jimmunol.164.1.107. J Immunol. 2000. PMID: 10605000

6

Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established Lewis lung carcinoma.

Chu Y, Wang LX, Yang G, Ross HJ, Urba WJ, Prell R, Jooss K, Xiong S, Hu HM. Chu Y, et al. J Immunother. 2006 Jul-Aug;29(4):367-80. doi: 10.1097/01.cji.0000199198.43587.ba. J Immunother. 2006. PMID: 16799332

7

CTL hyporesponsiveness induced by 2,3,7, 8-tetrachlorodibenzo-p-dioxin: role of cytokines and apoptosis.

Prell RA, Dearstyne E, Steppan LG, Vella AT, Kerkvliet NI. Prell RA, et al. Toxicol Appl Pharmacol. 2000 Aug 1;166(3):214-21. doi: 10.1006/taap.2000.8971. Toxicol Appl Pharmacol. 2000. PMID: 10906285

8

The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration.

Prell RA, Gearin L, Simmons A, Vanroey M, Jooss K. Prell RA, et al. Cancer Immunol Immunother. 2006 Oct;55(10):1285-93. doi: 10.1007/s00262-005-0116-4. Epub 2006 Jan 12. Cancer Immunol Immunother. 2006. PMID: 16408214 Free PMC article.

9

Administration of IFN-alpha enhances the efficacy of a granulocyte macrophage colony stimulating factor-secreting tumor cell vaccine.

Prell RA, Li B, Lin JM, VanRoey M, Jooss K. Prell RA, et al. Cancer Res. 2005 Mar 15;65(6):2449-56. doi: 10.1158/0008-5472.CAN-04-1975. Cancer Res. 2005. PMID: 15781661

10

Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.

Li B, Lalani AS, Harding TC, Luan B, Koprivnikar K, Huan Tu G, Prell R, VanRoey MJ, Simmons AD, Jooss K. Li B, et al. Clin Cancer Res. 2006 Nov 15;12(22):6808-16. doi: 10.1158/1078-0432.CCR-06-1558. Clin Cancer Res. 2006. PMID: 17121902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters